Brain metastasis of ovarian cancer >20 years after initial diagnosis: A case report

Brain metastasis from ovarian cancer, particularly from clear cell ovarian cancer, is extremely rare and its pathology remains unclear. In the present study we treated a patient in whom this cancer was diagnosed after chemotherapy was administered for lung metastases. The patient, a 76-year-old woman, presented to Department of Obstetrics and Gynecology, Showa General Hospital (Tokyo, Japan) in February 2025 with sudden confusion and dizziness. The patient was surgically treated for ovarian cancer 20 years previously that displayed two clear histological types: Left clear cell and mucinous carcinomas and right endometrioid carcinoma. The patient was treated several times for recurrent metastases in the umbilicus and inguinal lymph nodes, of either clear cell or endometrioid carcinoma. The treatment administered varied from resection to radiotherapy. In 2016, lung metastasis was suspected, but the lesion size remained unchanged for several years. In 2019, the left inguinal lymph node again became swollen, and re-irradiation was performed for 2 weeks. In 2023, the right lung metastases grew larger and palliative radiotherapy was administered at another hospital. The right lung metastases continued to grow, and the patient returned to our hospital in May 2024 with a severe cough; metastasis from ovarian cancer was diagnosed. Paclitaxel-carboplatin chemotherapy was resumed for 6 months; the tumor grew slightly smaller, and the severe cough disappeared. The patient underwent maintenance olaparib therapy from January 2025 for platinum-sensitive recurrent ovarian cancer. After presenting to our department in February 2025, imaging studies revealed multiple substantial brain metastases and growth of the lung metastases. Palliative whole brain radiotherapy was administered, with the confusion improving slightly. The patient was transferred to a nursing home. Multiple pathological types coexisted in our patient, creating a complicated condition that, after various treatments were administered, was difficult to comprehend. Appropriate pathological diagnosis through biopsy, as well as comprehensive consideration of the treatment strategy based on the characteristics of the pathological type, is necessary.

Authors

Institutions

Publication Details

Journal
Oncology Letters
Published
2025-10-23
DOI
https://doi.org/10.3892/ol.2025.15357
Primary Topic
Brain Metastases and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Brain metastasis of ovarian cancer >20 years after initial diagnosis: A case report

Chihiro Ishizawa, Akira Tsuchiya, Yuki Kambe, Kazuaki Neriishi et al.
Oncology Letters
Brain Metastases and Treatment
article

Brain metastasis of ovarian cancer >20 years after initial diagnosis: A case report

Chihiro Ishizawa, Akira Tsuchiya, Yuki Kambe, Kazuaki Neriishi, Kazunari Miyazawa, Misaki Tani
article en

Abstract

Brain metastasis from ovarian cancer, particularly from clear cell ovarian cancer, is extremely rare and its pathology remains unclear. In the present study we treated a patient in whom this cancer was diagnosed after chemotherapy was administered for lung metastases. The patient, a 76-year-old woman, presented to Department of Obstetrics and Gynecology, Showa General Hospital (Tokyo, Japan) in February 2025 with sudden confusion and dizziness. The patient was surgically treated for ovarian cancer 20 years previously that displayed two clear histological types: Left clear cell and mucinous carcinomas and right endometrioid carcinoma. The patient was treated several times for recurrent metastases in the umbilicus and inguinal lymph nodes, of either clear cell or endometrioid carcinoma. The treatment administered varied from resection to radiotherapy. In 2016, lung metastasis was suspected, but the lesion size remained unchanged for several years. In 2019, the left inguinal lymph node again became swollen, and re-irradiation was performed for 2 weeks. In 2023, the right lung metastases grew larger and palliative radiotherapy was administered at another hospital. The right lung metastases continued to grow, and the patient returned to our hospital in May 2024 with a severe cough; metastasis from ovarian cancer was diagnosed. Paclitaxel-carboplatin chemotherapy was resumed for 6 months; the tumor grew slightly smaller, and the severe cough disappeared. The patient underwent maintenance olaparib therapy from January 2025 for platinum-sensitive recurrent ovarian cancer. After presenting to our department in February 2025, imaging studies revealed multiple substantial brain metastases and growth of the lung metastases. Palliative whole brain radiotherapy was administered, with the confusion improving slightly. The patient was transferred to a nursing home. Multiple pathological types coexisted in our patient, creating a complicated condition that, after various treatments were administered, was difficult to comprehend. Appropriate pathological diagnosis through biopsy, as well as comprehensive consideration of the treatment strategy based on the characteristics of the pathological type, is necessary.

Oncology LettersVol. 31(1)
Showa General Hospital (JP)
Openalex Percentile: Top 57%
Brain Metastases and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.